Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
DMTK DermTech
2.690
+0.010+0.37%
Post Mkt Price
2.630
-0.060-2.23%
YOY
Do not show
Hide blank lines
(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31
Total revenue
17.92% 3.57M 35.72% 4.23M 47.31% 3.72M 101.16% 11.84M
Operating revenue
17.92% 3.57M 35.72% 4.23M 47.31% 3.72M 101.16% 11.84M
Cost of revenue
27.47% 3.69M 24.73% 3.27M 77.52% 3.55M 76.63% 10.56M
Gross profit
-191.67% -121K 93.94% 960K -68.58% 164K 1,427.08% 1.27M
Operating expense
42.49% 29.14M 72.98% 30.79M 117.83% 30.36M 123.54% 78.67M
Selling and administrative expenses
46.26% 23.44M 68.07% 23.88M 105.55% 24.02M 108.73% 62.41M
-Selling and marketing expense
48.91% 14.63M 89.72% 15M 137.15% 15.44M 133.72% 37.58M
-General and administrative expense
42.06% 8.81M 40.90% 8.88M 65.78% 8.57M 79.67% 24.84M
Research and development costs
28.83% 5.7M 92.40% 6.92M 181.56% 6.34M 207.22% 16.26M
Operating profit
-44.01% -29.26M -72.38% -29.83M -125.09% -30.19M -119.33% -77.4M
Net non-operating interest income expense
1,176.32% 485K 325.71% 149K 94.12% 66K 277.50% 151K
Non-operating interest income
1,176.32% 485K 325.71% 149K 94.12% 66K -- 151K
Other net income (expense)
-97.63% 4K -38.24% 105K 101.01% 17K -1.09M
Gain on sale of security
-97.63% 4K -38.24% 105K 101.01% 17K -- -1.09M
Special income (charges)
-- -- -- -- -- -- -- 0
Income before tax
-43.06% -28.77M -72.96% -29.58M -99.81% -30.11M -122.23% -78.34M
Income tax
Net income
-43.06% -28.77M -72.96% -29.58M -99.81% -30.11M -122.23% -78.34M
Net income continuous Operations
-43.06% -28.77M -72.96% -29.58M -99.81% -30.11M -122.23% -78.34M
Minority interest income
Net income attributable to the parent company
-43.06% -28.77M -72.96% -29.58M -99.81% -30.11M -122.23% -78.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-43.06% -28.77M -72.96% -29.58M -99.81% -30.11M -122.23% -78.34M
Basic earnings per share
-41.18% -0.96 -67.80% -0.99 -83.64% -1.01 -30.29% -2.71
Diluted earnings per share
-41.18% -0.96 -67.80% -0.99 -83.64% -1.01 -30.29% -2.71
Dividend per share
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
------Unqualified Opinion with Explanation

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
DermTech, Inc. engages in the development and sale of products for the diagnosis and treatment of skin diseases. It markets and develops products that facilitate diagnosis and management of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. Its products and services include melanoma test, smart sticker, and telemedicine option for melanoma test. The company was founded in 1995 and is headquartered in La Jolla, CA.
CEO: Dr. John D Dobak, M.D.
Market: NASDAQ
Listing Date: 06/20/2017
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist